WHO: Michael Simpson
WHAT: President + CEO
Caradigm identifies and stratifies the risk in your population to improve clinical outcomes and financial results. Caradigm equips your organization to keep a patient population as healthy as possible while managing utilization to lower costs.
Today’s notes and discussion guide:
There seems to be a lot of ongoing debate about Meaningful Use requirements and timelines, as well as mixed feedback on the adoption of Electronic Health Records. What’s your perspective on EHR adoption/value and the progress being made toward meeting Meaningful Use objectives?”
What capabilities are needed beyond what typical EHRs provide to achieve Stage 2 Meaningful Use as well as broader goals for population health?
Can you talk more specifically about the tools or solutions you believe providers need to achieve their goals for improved quality, outcomes and population health?
You mentioned Care Management as one of the four capabilities. I often think of Care Management in the payer domain. What does Caradigm offer in Care Management for providers?
What other applications are part of your population health portfolio?
About Michael Simpson:
Michael Simpson is the CEO of Caradigm accountable to the company’s Board of Directors. Before being named CEO of Caradigm, Michael served as general manager for GE Healthcare IT. In that role, he was responsible for product management, marketing, engineering and service strategies for Qualibria, a groundbreaking clinical knowledge platform.
Michael has more than 25 years of domestic and international experience across various market segments, including healthcare IT, telecommunications, media and high-tech industries. Prior to joining GE, he was senior vice president of product strategy and development at QuadraMed Corp. Michael also held several executive roles at McKesson Corp., including senior vice president and chief technology officer, McKesson Provider Technologies; senior vice president and chief technology officer for McKesson Technology Solutions’ international operations; and senior vice president and general manager, Horizon Clinicals.